Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3CD | O00329 | 11/20 | 0.44 |
| ▸ | PIK3CA | P42336 | 9/20 | 0.44 |
| ▸ | MTOR | P42345 | 7/20 | 0.44 |
| ▸ | PIK3CG | P48736 | 2/20 | 0.44 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.44 |
| ▸ | NAMPT | P43490 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8091267 | 0.88 | PIK3CA (0.46) | PIK3CDPIK3CAMTORPIK3CGPIK3CB | |
| SCHEMBL8091758 | 0.88 | PIK3CD (0.43) | PIK3CDPIK3CAMTORPIK3CGPIK3CB | |
| SCHEMBL8089128 | 0.86 | PIK3CD (0.44) | PIK3CDPIK3CAMTORPIK3CGPIK3CB | |
| SCHEMBL8099039 | 0.86 | PIK3CD (0.49) | PIK3CDPIK3CAMTORPIK3CGPIK3CB | |
| SCHEMBL8099965 | 0.85 | NAMPT (0.39) | PIK3CDPIK3CANAMPT | |
| SCHEMBL8094369 | 0.84 | PIK3CD (0.44) | PIK3CDPIK3CAMTORPIK3CGPIK3CB | |
| SCHEMBL8097552 | 0.84 | PIK3CA (0.44) | PIK3CDPIK3CAMTORPIK3CGPIK3CB | |
| SCHEMBL8084799 | 0.84 | PIK3CA (0.51) | PIK3CDPIK3CAMTORPIK3CGPIK3CB | |
| SCHEMBL8090008 | 0.84 | PIK3CA (0.51) | PIK3CDPIK3CAMTORPIK3CGPIK3CB | |
| SCHEMBL8097253 | 0.83 | PIK3CD (0.36) | PIK3CDPIK3CAMTORNAMPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2009007748-A2 | TRISUBSTITUTED PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF PROLIFERATIVE DISEASES | ASTRAZENECA AB (SE) | 2009-01-15 | — | — | WO | disclosed |